RNAC — Cartesian Therapeutics Inc. · P/E 2.1, rev $78.0K

Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.

Latest reported RNAC revenue for 2026-06-30 was $78.0K. Net income was -$23.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.

Use this RNAC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RNAC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RNAC SEC filings page. Lician reads the product cache first so this HTML stays unique to Cartesian Therapeutics Inc. even when a live quote feed is slow.